0.8502
+0.0330
+(4.04%)
At close: January 10 at 8:36:50 AM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 4 | 6 | 7 |
Avg. Estimate | -- | 12.5M | -- | 29.86M |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | 50M | -- | 125M |
Year Ago Sales | 64k | -- | 126.33M | -- |
Sales Growth (year/est) | -100.00% | 0.00% | -100.00% | 0.00% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
1S9.F | -- | -- | -- | -- |
S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
Maintains | Canaccord Genuity: Buy to Buy | 11/14/2024 |
Maintains | Chardan Capital: Buy to Buy | 11/13/2024 |
Downgrade | JP Morgan: Neutral to Underweight | 10/24/2024 |
Maintains | Canaccord Genuity: Buy to Buy | 9/13/2024 |
Maintains | Canaccord Genuity: Buy to Buy | 8/14/2024 |
Maintains | Chardan Capital: Buy to Buy | 8/14/2024 |
Related Tickers
ZK7.BE Conduit Pharmaceuticals Inc
0.1260
+57.50%
ZK7.F Conduit Pharmaceuticals Inc.
0.0705
0.00%
FNCH Finch Therapeutics Group, Inc.
10.90
0.00%
SYBX Synlogic, Inc.
1.4701
+2.09%
ADAG Adagene Inc.
1.9350
-1.28%
SNPX Synaptogenix, Inc.
3.1300
-13.54%
LIXT Lixte Biotechnology Holdings, Inc.
2.5900
+12.61%
NXTC NextCure, Inc.
0.7990
-6.11%
BCDA BioCardia, Inc.
2.1264
-3.35%
APRE Aprea Therapeutics, Inc.
3.6550
-7.47%